CHD vs PBH
CHD: A consumer staples company anchored by iconic, high-margin power brands across household, personal care, and specialty chemical markets. PBH: Prestige Consumer Healthcare is a branded OTC healthcare company that manages a diverse portfolio of essential household and personal care products.
Side-by-side fundamentals
| Metric | CHD | PBH | Edge |
|---|---|---|---|
| Price as of 2026-10-21 close | $105.00 | $47.92 | |
| Market cap | $24.9B | $2.3B | |
| P/E as of 2026-10-21 | 33.65 | 13.42 | PBH lower |
| PEG as of 2026-10-21, 3-year EPS CAGR to FY2025 | 1.56 | n/a | |
| Net margin | +11.9% | +17.5% | PBH higher |
| Gross margin | +44.7% | +54.7% | PBH higher |
| Operating margin | +17.4% | +28.4% | PBH higher |
| ROE | +18.4% | +10.1% | CHD higher |
| ROA | +8.3% | +5.4% | CHD higher |
| Debt / equity filed borrowings, leases excl., balance sheet 2026-06-30 | 0.53 | 1.05 | CHD lower |
| Revenue growth (YoY) | +1.6% | -4.3% | CHD higher |
| Revenue CAGR (3y) SEC XBRL | +4.9% | -1.2% | CHD higher |
| Dividend yield as of 2026-09-03 | +1.3% | n/a | |
| Dividend streak (yrs) SEC XBRL | 18 | 0 | CHD higher |
| Beta as of 2026-09-03 | 0.03 | 0.39 | |
| 1-year return as of 2026-10-21 close | +19.3% | -23.3% | CHD higher |
Fundamentals: SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-03 for the rest. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-10-21.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.